Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE ConferenceEvan S. Dellon, Alain Schoepfer, Peter A Bonis et al.|Gastroenterology|2018Cited by 1.1k
Budesonide Oral Suspension Improves Symptomatic, Endoscopic, and Histologic Parameters Compared With Placebo in Patients With Eosinophilic EsophagitisEvan S. Dellon, Vincent A. Mukkada, David A. Katzka et al.|Gastroenterology|2016Cited by 228
International Consensus Recommendations for Eosinophilic Gastrointestinal Disease NomenclatureEvan S. Dellon, Vincent A. Mukkada, Nirmala Gonsalves et al.|Clinical Gastroenterology and Hepatology|2022Cited by 175
One-food versus six-food elimination diet therapy for the treatment of eosinophilic oesophagitis: a multicentre, randomised, open-label trialKara Kliewer, Marc E. Rothenberg, Nirmala Gonsalves et al.|The Lancet. Gastroenterology & hepatology|2023Cited by 148
Development of a core outcome set for therapeutic studies in eosinophilic esophagitis (COREOS)Christopher Ma, Philip E. Putnam, Alain Schoepfer et al.|Journal of Allergy and Clinical Immunology|2021Cited by 82